229 related articles for article (PubMed ID: 16948829)
1. Comparison of the efficacy of calcipotriol and maxacalcitol in combination with narrow-band ultraviolet B therapy for the treatment of psoriasis vulgaris.
Noborio R; Kobayashi K; Shintani Y; Morita A
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):262-4. PubMed ID: 16948829
[TBL] [Abstract][Full Text] [Related]
2. Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis.
Roussaki-Schulze AV; Kouskoukis C; Klimi E; Zafiriou E; Galanos A; Rallis E
Drugs Exp Clin Res; 2005; 31(5-6):169-74. PubMed ID: 16425972
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
[TBL] [Abstract][Full Text] [Related]
4. Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure.
Adachi Y; Uchida N; Matsuo T; Horio T
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):16-8. PubMed ID: 18201352
[TBL] [Abstract][Full Text] [Related]
5. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
[TBL] [Abstract][Full Text] [Related]
6. Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients.
Rim JH; Choe YB; Youn JI
Photodermatol Photoimmunol Photomed; 2002 Jun; 18(3):131-4. PubMed ID: 12207676
[TBL] [Abstract][Full Text] [Related]
7. Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group.
Ramsay CA; Schwartz BE; Lowson D; Papp K; Bolduc A; Gilbert M
Dermatology; 2000; 200(1):17-24. PubMed ID: 10681608
[TBL] [Abstract][Full Text] [Related]
8. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis.
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Br J Dermatol; 2000 Dec; 143(6):1275-8. PubMed ID: 11122033
[TBL] [Abstract][Full Text] [Related]
9. UVB versus UVB plus calcipotriol (MC 903) therapy for psoriasis vulgaris.
Kokelj F; Lavaroni G; Guadagnini A
Acta Derm Venereol; 1995 Sep; 75(5):386-7. PubMed ID: 8615059
[TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis vulgaris with narrow-band UVB and topical Maxacalcitol.
Takekoshi T; Asahina A; Komine M; Tamaki K
Acta Derm Venereol; 2006; 86(4):375-6. PubMed ID: 16874435
[No Abstract] [Full Text] [Related]
11. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
[TBL] [Abstract][Full Text] [Related]
12. Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial.
Woo WK; McKenna KE
Br J Dermatol; 2003 Jul; 149(1):146-50. PubMed ID: 12890208
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
14. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.
Torras H; Aliaga A; López-Estebaranz JL; Hernández I; Gardeazabal J; Quintanilla E; Mascaró JM
J Dermatolog Treat; 2004 Apr; 15(2):98-103. PubMed ID: 15204160
[TBL] [Abstract][Full Text] [Related]
15. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.
Barker JN; Ashton RE; Marks R; Harris RI; Berth-Jones J
Br J Dermatol; 1999 Aug; 141(2):274-8. PubMed ID: 10468799
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis.
Hofmann UB; Eggert AA; Bröcker EB; Goebeler M
Br J Dermatol; 2003 Apr; 148(4):779-83. PubMed ID: 12752138
[TBL] [Abstract][Full Text] [Related]
17. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
Bourke JF; Iqbal SJ; Hutchinson PE
Clin Exp Dermatol; 1997 Nov; 22(6):259-61. PubMed ID: 9604449
[TBL] [Abstract][Full Text] [Related]
18. Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group.
Molin L
Dermatology; 1999; 198(4):375-81. PubMed ID: 10490297
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
20. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
